Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post Zweig Breadth Thrust Dominates the Headlines – But What about an Exit Strategy? April 28, 2025 Related Posts Locksley Resources LimitedLt. Gen.Schwartz to Advance US Defense Strategy December 15, 2025 ReeXploration Announces $1,000,000 Private Placement December 15, 2025 FORTUNE BAY PROVIDES UPDATE ON POMA ROSA PROJECT, CHIAPAS STATE, MEXICO December 15, 2025